Bernard J. Zovighian is CEO and on the Board of Directors of Edwards Lifesciences since May 2023, after serving as the company’s president. As CEO, Zovighian is leading Edwards into a new era of groundbreaking structural heart innovation, with a sharpened focus and pursuit of expanded opportunities to transform the care of structural heart patients worldwide. Building from Edwards’ foundation rooted in the company’s Credo, the patient-focused culture and the unique innovation strategy, Zovighian and the global Edwards employees are united and inspired to enable the company’s sustainable growth and extend its global leadership.
With a career spanning nearly three decades in medical technology, Zovighian has led global businesses across two world-class companies, during which time he lived and led teams in several countries. Zovighian blends a global mindset and a team-based approach to leadership with strengths in strategy development, innovation and adoption of disruptive technologies that elevate the standard of care, and establishment of trusted partnerships.
Zovighian joined Edwards Lifesciences in January 2015 as vice president and general manager of the Surgical Structural Heart business, and he later served as corporate vice president of the surgical business from 2016 until he became corporate vice president responsible for the company’s Transcatheter Mitral and Tricuspid Therapies (TMTT) business in January 2018. Zovighian established a global organization focused on developing a portfolio of therapies designed to change the standard of care for mitral and tricuspid patients. Prior to joining Edwards, Zovighian held roles with increasing levels of responsibility at Johnson & Johnson (J&J) for nearly 20 years, including worldwide president of one of the company’s divisions.
Currently, Zovighian serves as an advisory board member for the Leonard D. Schaeffer Center for Health Policy & Economics at the University of Southern California. He has dual master’s degrees in science and business from Universities of Marseille, France.
Member Company since 2025